Breaking news

This case-control study enrolled 58 COVID-19 positive and 62 COVID-19 negative patients, matched for age, gender and neurological admission causes, including brain tumors, encephalopathy, headache, epilepsy, stroke, transient ischemic attack, subarachnoid hemorrhage and peripheral nerves diseases.

Breaking News: Diagnosis and management of migraine in ten steps

Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review

COVID-19 Infection and Parkinsonism: Is There a Link?

Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis

COVID-19 associated brain/spinal cord lesions and leptomeningeal enhancement: A meta-analysis of the relationship to CSF SARS-CoV-2

Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions

Cerebrospinal fluid from COVID-19 patients with olfactory/gustatory dysfunction: A review

Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the Virus on Neurocognitive Trajectories

Systematic Review of Cases of Acute Myelitis in Individuals with COVID-19

COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival

Persistent visual dysfunction following PRES due to COVID-19: Case series and literature review

Risk and outcomes of COVID-19 in patients with multiple sclerosis

Predictive factors of smell recovery in a clinical series of 288 COVID-19 patients with olfactory dysfunction